Literature DB >> 25433412

Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT.

Naohiro Furuhashi1, Kojiro Suzuki, Yusuke Sakurai, Mitsuru Ikeda, Yuichi Kawai, Shinji Naganawa.   

Abstract

OBJECTIVES: To evaluate the utility of multiphase contrast-enhanced computed tomography (CT) findings alone and in combination for differentiating focal-type autoimmune pancreatitis (f-AIP) from pancreatic carcinoma (PC).
METHODS: The study group comprised 22 f-AIP lesions and 61 PC lesions. Two radiologists independently evaluated CT findings. Frequencies of findings were compared between f-AIP and PC. Statistical, univariate and multivariate analyses were performed.
RESULTS: Homogeneous enhancement during the portal phase (AIP, 59 % vs. PC, 3 %; P < 0.001), dotted enhancement during the pancreatic phase (50 % vs. 7 %; P < 0.001), duct-penetrating sign (46 % vs. 2 %; P < 0.001), enhanced duct sign (36 % vs. 2 %; P < 0.001) and capsule-like rim (46 % vs. 3 %; P < 0.001) were more frequently observed in AIP. Ring-like enhancement during the delayed phase (5 % vs. 46 %; P < 0.001) and peripancreatic strands with a length of at least 10 mm (5 % vs. 39 %; P = 0.001) were more frequently observed in PC. AIP was identified with 82 % sensitivity and 98 % specificity using four of these seven findings. Multivariate analysis revealed significant differences in dotted enhancement (P = 0.004), duct-penetrating sign (P < 0.001) and capsule-like rim (P = 0.007).
CONCLUSIONS: The combination of CT findings may allow improvements in differentiating f-AIP from PC. KEY POINTS: • f-AIP can mimic PC on imaging findings. • The differentiation of f-AIP from PC is important in patient management. • Some CT findings can be used to identify AIP. • The combination of CT findings will improve differentiation from PC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25433412     DOI: 10.1007/s00330-014-3512-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  29 in total

1.  Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings.

Authors:  Ali Muhi; Tomoaki Ichikawa; Utaroh Motosugi; Hironobu Sou; Katsuhiro Sano; Tatsuaki Tsukamoto; Zareen Fatima; Tsutomu Araki
Journal:  J Magn Reson Imaging       Date:  2011-11-08       Impact factor: 4.813

Review 2.  Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis.

Authors:  M J Levy; M J Wiersema; S T Chari
Journal:  Endoscopy       Date:  2006-06       Impact factor: 10.093

3.  Autoimmune pancreatitis: radiologic findings in 20 patients.

Authors:  D H Yang; K W Kim; T K Kim; S H Park; S H Kim; M H Kim; S K Lee; A Y Kim; P N Kim; H K Ha; M-G Lee
Journal:  Abdom Imaging       Date:  2005-12-07

4.  Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens.

Authors:  Giuseppe Zamboni; Jutta Lüttges; Paola Capelli; Luca Frulloni; Giorgio Cavallini; Paolo Pederzoli; Alexander Leins; Daniel Longnecker; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-10-27       Impact factor: 4.064

Review 5.  Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT.

Authors:  Satomi Kawamoto; Stanley S Siegelman; Ralph H Hruban; Elliot K Fishman
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

Review 6.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 7.  Staging cancer of the pancreas.

Authors:  G Morana; L Cancian; R Pozzi Mucelli; C Cugini
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  Autoimmune pancreatitis: imaging features.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; James Farrell; Michael M Maher; Sanjay Saini; Peter R Mueller; Gregory Y Lauwers; Carlos D Fernandez; Andrew L Warshaw; Joseph F Simeone
Journal:  Radiology       Date:  2004-09-30       Impact factor: 11.105

9.  Standard steroid treatment for autoimmune pancreatitis.

Authors:  T Kamisawa; T Shimosegawa; K Okazaki; T Nishino; H Watanabe; A Kanno; F Okumura; T Nishikawa; K Kobayashi; T Ichiya; H Takatori; K Yamakita; K Kubota; H Hamano; K Okamura; K Hirano; T Ito; S B H Ko; M Omata
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis?

Authors:  Sung-Jo Bang; Myung-Hwan Kim; Do Ha Kim; Tae Yoon Lee; Seunghyun Kwon; Hyoung-Chul Oh; Ji Young Kim; Chang Yun Hwang; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee; Dong Eun Song; Se Jin Jang
Journal:  Pancreas       Date:  2008-01       Impact factor: 3.327

View more
  12 in total

1.  Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.

Authors:  Sunyoung Lee; Jin Hee Kim; So Yeon Kim; Jae Ho Byun; Hyoung Jung Kim; Myung-Hwan Kim; Moon-Gyu Lee; Seung Soo Lee
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

2.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

Review 3.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 4.  American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists.

Authors:  Hainan Ren; Naoko Mori; Satoko Sato; Shunji Mugikura; Atsushi Masamune; Kei Takase
Journal:  Jpn J Radiol       Date:  2022-04-27       Impact factor: 2.701

5.  Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.

Authors:  Chuangen Guo; Xiao Chen; Zhongqiu Wang; Wenbo Xiao; Qidong Wang; Ke Sun; Xiaoling Zhuge
Journal:  Oncotarget       Date:  2017-06-27

6.  A feasible CT feature to differentiate focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.

Authors:  Chaobin He; Dailin Rong; Wanming Hu; Qian Cai; Qiuxia Yang; Yize Mao; Rong Zhang; Shengping Li; Yanchun Lv
Journal:  Cancer Med       Date:  2019-08-30       Impact factor: 4.452

Review 7.  Focal Autoimmune Pancreatitis: A Simple Flow Chart for a Challenging Diagnosis.

Authors:  Clara Benedetta Conti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  Ultrasound Int Open       Date:  2021-01-19

8.  Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed Tomography.

Authors:  Linning E; Yan Xu; Zhifeng Wu; Li Li; Na Zhang; Hao Yang; Lawrence H Schwartz; Lin Lu; Binsheng Zhao
Journal:  J Comput Assist Tomogr       Date:  2020 Jul/Aug       Impact factor: 2.081

9.  Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.

Authors:  Ting-Ting Zhang; Li Wang; Huan-Huan Liu; Cai-Yuan Zhang; Xiao-Ming Li; Jian-Ping Lu; Deng-Bin Wang
Journal:  Oncotarget       Date:  2017-01-03

Review 10.  Abdominal manifestations of IgG4-related disease: a pictorial review.

Authors:  Christopher Siew Wai Tang; Nishanth Sivarasan; Nyree Griffin
Journal:  Insights Imaging       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.